PICTET BANK & TRUST Ltd decreased its holdings in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 35.4% in the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 2,555 shares of the healthcare conglomerate's stock after selling 1,400 shares during the period. UnitedHealth Group accounts for about 0.9% of PICTET BANK & TRUST Ltd's portfolio, making the stock its 28th biggest holding. PICTET BANK & TRUST Ltd's holdings in UnitedHealth Group were worth $797,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in UNH. Vanguard Group Inc. boosted its position in UnitedHealth Group by 6.6% during the 1st quarter. Vanguard Group Inc. now owns 90,729,585 shares of the healthcare conglomerate's stock valued at $47,519,620,000 after acquiring an additional 5,583,343 shares in the last quarter. Wellington Management Group LLP raised its stake in shares of UnitedHealth Group by 10.6% during the 1st quarter. Wellington Management Group LLP now owns 25,847,940 shares of the healthcare conglomerate's stock valued at $13,537,859,000 after buying an additional 2,486,839 shares during the last quarter. GAMMA Investing LLC raised its stake in shares of UnitedHealth Group by 56,142.1% during the 1st quarter. GAMMA Investing LLC now owns 8,295,153 shares of the healthcare conglomerate's stock valued at $4,344,586,000 after buying an additional 8,280,404 shares during the last quarter. Bank of New York Mellon Corp raised its stake in shares of UnitedHealth Group by 2.5% during the 1st quarter. Bank of New York Mellon Corp now owns 8,128,174 shares of the healthcare conglomerate's stock valued at $4,257,131,000 after buying an additional 196,696 shares during the last quarter. Finally, Nuveen LLC purchased a new position in shares of UnitedHealth Group in the 1st quarter valued at about $3,846,764,000. 87.86% of the stock is owned by institutional investors.
Analysts Set New Price Targets
Several brokerages have recently weighed in on UNH. UBS Group restated a "buy" rating on shares of UnitedHealth Group in a report on Thursday, July 17th. Robert W. Baird reiterated an "underperform" rating and set a $198.00 target price (down previously from $312.00) on shares of UnitedHealth Group in a research note on Thursday, July 31st. JPMorgan Chase & Co. reduced their price objective on shares of UnitedHealth Group from $418.00 to $310.00 and set an "overweight" rating for the company in a research report on Wednesday, August 6th. KeyCorp dropped their target price on shares of UnitedHealth Group from $400.00 to $350.00 and set an "overweight" rating for the company in a report on Wednesday, July 30th. Finally, Baird R W cut shares of UnitedHealth Group from a "hold" rating to a "strong sell" rating in a research note on Thursday, July 31st. Sixteen analysts have rated the stock with a Buy rating, six have issued a Hold rating and three have given a Sell rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $358.95.
Get Our Latest Stock Report on UnitedHealth Group
UnitedHealth Group Stock Performance
Shares of UNH opened at $341.49 on Tuesday. The company has a debt-to-equity ratio of 0.73, a quick ratio of 0.85 and a current ratio of 0.85. UnitedHealth Group Incorporated has a twelve month low of $234.60 and a twelve month high of $630.73. The firm's 50 day moving average price is $296.49 and its two-hundred day moving average price is $362.50. The firm has a market cap of $309.27 billion, a P/E ratio of 14.80, a PEG ratio of 2.20 and a beta of 0.44.
UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing the consensus estimate of $4.45 by ($0.37). UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The firm had revenue of $111.62 billion for the quarter, compared to the consensus estimate of $111.75 billion. During the same period last year, the company posted $6.80 earnings per share. The business's revenue was up 12.9% compared to the same quarter last year. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. On average, analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.
UnitedHealth Group Announces Dividend
The company also recently declared a quarterly dividend, which will be paid on Tuesday, September 23rd. Shareholders of record on Monday, September 15th will be given a dividend of $2.21 per share. This represents a $8.84 annualized dividend and a yield of 2.6%. The ex-dividend date of this dividend is Monday, September 15th. UnitedHealth Group's dividend payout ratio is 38.30%.
About UnitedHealth Group
(
Free Report)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Featured Stories
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.